{
  "id": "SCR-LIP-000781",
  "statement": "Findings are inconsistent on whether quality-of-life and psychological burden worsen with more advanced lipedema stage.",
  "claim_type": "clinical_association",
  "context": {
    "population": "lipedema patients, self-reported stages 1–4",
    "condition": "lipedema",
    "exposure": "advanced lipedema stage (3–4)",
    "comparator": "early lipedema stage (1–2)",
    "outcome": "depression, social isolation, life dissatisfaction, mobility loss",
    "scope": "auto-ingested from Layer 1 surveillance"
  },
  "knowledge_state": "emerging",
  "evidence_confidence": "low",
  "evidence": [
    {
      "ref": "DOI:10.1007/s11136-022-03216-w",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2023,
      "amato_authored": false,
      "note": "Large cross-sectional survey directly reports depression, anxiety-related symptoms (fearfulness), social isolation, and life dissatisfaction in lipedema patients, with worse outcomes at advanced stages; findings are self-reported and unadju",
      "title": "Stages of lipoedema: experiences of physical and mental health and health care",
      "authors": "Clarke et al.",
      "journal": "Quality of Life Research",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": false,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "verified by verifier; quote not verbatim-grounded. All specific numbers cited in the statement (depression 48.3% vs 34.8%, social isolation 64.3% vs 44.4%, life dissatisfaction 35.7% vs 22.0%, inferiority complex 72.8%, constantly thinking ",
        "date": "2026-06-10"
      },
      "quote": "Depressão: Estágio 3–4 = 48,3% vs Estágio 1–2 = 34,8% (χ²=22,78, p<0,001)",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "Stage 3-4 vs 1-2: depression 48.3% vs 34.8% (p<0.001), staying home 64.3% vs 44.4%, life dissatisfaction 35.7% vs 22.0%; inferiority feelings high across stages.",
      "from_claims": [
        "SCR-LIP-000349"
      ]
    },
    {
      "ref": "DOI:10.3390/jcm11102836",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2022,
      "amato_authored": false,
      "note": "Large cross-sectional study using validated PROMs (WHOQOL-BREF, PHQ-9) directly quantifying quality of life and depression in lipedema patients, with stage-dependent correlations; directly addresses the question's affirmative direction.",
      "title": "Characteristics and Patient Reported Outcome Measures in Lipedema Patients—Establishing a Baseline for Treatment Evaluation in a High-Volume Center",
      "authors": "Hamatschek et al.",
      "journal": "Journal of Clinical Medicine",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": false,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "verified by verifier; quote not verbatim-grounded. All specific numbers in the statement (PHQ-9 mean 10.84±6.39, 54% at risk of moderate-to-severe depression, WHOQOL-BREF global 60.5±16.02, physical domain 54.54, psychological domain 51.91,",
        "date": "2026-06-10"
      },
      "quote": "PHQ-9: média 10,84±6,39; 54,01% em risco de depressão moderada a severa; correlação estágio-PHQ-9: r=0,2, p=0,002; correlação incapacidade profissional-PHQ-9: r=0,413, p<0,001",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "In 511 patients, QoL impairment correlated with stage (r=0.55, p<0.001) and PHQ-9 with stage (r=0.2, p=0.002); PHQ-9 mean 10.84, 54% at risk of moderate-to-severe depression.",
      "from_claims": [
        "SCR-LIP-000355"
      ]
    },
    {
      "ref": "DOI:10.1371/journal.pone.0319099",
      "stance": "refines",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "moderate",
      "year": 2025,
      "amato_authored": false,
      "note": "Retrospective referral-centre study with validated instruments (SF-36, HADS, BPI, FSS) directly quantifying quality of life, depression, and anxiety in lipedema patients, showing high psychosocial burden dissociated from disease stage.",
      "title": "Clinical characteristics, comorbidities, and correlation with advanced lipedema stages: A retrospective study from a Swiss referral centre",
      "authors": "Luta et al.",
      "journal": "PLOS ONE",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": false,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "verified by verifier; quote not verbatim-grounded. The article abstract explicitly reports anxiety (HADS≥8) in 64.4%, depression (HADS≥8) in 23.4%, low quality of life in PCS-SF36 71.5% and MCS-SF36 67.4%, assessed in 239 patients with vali",
        "date": "2026-06-10"
      },
      "quote": "Burden psicossocial elevado (n=239): ansiedade (HADS≥8) 64,4%; depressão (HADS≥8) 23,4%; fadiga alta (FSS≥4) 56,1%; dor alta (BPI≥7) 14,2%; QV baixa: PCS-SF36 em 71,5%, MCS-SF36 em 67,4% — NENHUM desses parâmetros diferiu significativamente entre estágios (p>0,5)",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "In 239 patients, anxiety 64.4%, depression 23.4%, low PCS-SF36 71.5% and MCS-SF36 67.4%, with none of these differing significantly across disease stages (p>0.5).",
      "from_claims": [
        "SCR-LIP-000357"
      ]
    }
  ],
  "relations": [],
  "gaps": "",
  "curators": [],
  "created": "2026-11-20",
  "updated": "2026-11-20",
  "license": "CC-BY-4.0",
  "consolidated_from": [
    "SCR-LIP-000349",
    "SCR-LIP-000355",
    "SCR-LIP-000357"
  ],
  "questions_consolidated": [
    "SQ-LIP-000041"
  ],
  "provenance": {
    "method": "consolidation (R-CLM-19)",
    "store_key": "G-00226",
    "models": {
      "primary": "claude-opus-5.5 (Claude Code subagent, 1 repair round + arbitration)",
      "verifier": "claude-sonnet (Claude Code subagent, fresh context)",
      "mode": "agent"
    }
  },
  "history": [
    {
      "date": "2026-11-20",
      "event": "created_by_consolidation",
      "detail": "general proposition consolidated from SQ-LIP-000041"
    }
  ],
  "statement_pt": "Os achados são inconsistentes sobre se a qualidade de vida e a carga psicológica pioram com estágios mais avançados do lipedema.",
  "answers_questions": [
    {
      "id": "SQ-LIP-000041",
      "role": "refines",
      "question": "How does lipedema affect health-related quality of life?",
      "url": "https://scientificclaims.org/q/SQ-LIP-000041.html"
    }
  ],
  "url": "https://scientificclaims.org/c/SCR-LIP-000781.html"
}